Since US President Donald Trump – just days into his second term – began imposing tariffs on China for its role in the flow of deadly opioids like fentanyl into the United States, Beijing’s message ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the industry—and Washington—are rethinking the risks.

A drug that outperforms placebo in helping people to lose weight is one of a growing number of next-generation obesity drugs being produced in China. At first, Chinese pharmaceutical companies rushed ...

THE FIGHT against fentanyl, a synthetic opioid, is at the heart of America and China’s uneasy trade-war truce. The drug has killed more than 300,000 Americans since 2020 and related overdoses are the ...

In a major crackdown, border officials in the United States stopped a shipment of over 50,000 kilograms of chemical ingredients used to make illegal drugs. These chemicals came from China and were ...

It’s the most prescribed antibiotic in the United States, used by tens of millions of people every year to treat bacterial infections including pneumonia, stomach ulcers, and strep throat. Yet, it isn ...

China’s State Council updated its Drug Administration Law, and the changes mark a substantive evolution in the country’s drug regulatory framework.

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time regulators take to review clinical trials. In a draft policy posted (Chinese ...

A hand holds up a tamper-safe orange bottle filled with oblong white pills against a red-tinted background of Chinese yuan. As China’s biopharmaceutical industry churns out more innovative molecules, ...

China has unveiled its first state-backed catalog of costly innovative drugs for private insurers to cover, making the industry pick up more of the nation’s soaring health-care costs. Issued Dec. 7 by ...